Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE

por Panaccione, R, Colombel, J-F, Sandborn, W J, D'Haens, G, Zhou, Q, Pollack, P F, Thakkar, R B, Robinson, A M
Publicado 2013

Adalimumab for the treatment of fistulas in patients with Crohn’s disease

por Colombel, J-F, Schwartz, D A, Sandborn, W J, Kamm, M A, D’Haens, G, Rutgeerts, P, Enns, R, Panaccione, R, Schreiber, S, Li, J, Kent, J D, Lomax, K G, Pollack, P F
Publicado 2009